GLP-1 receptor agonists, with their proven track record for helping patients lose weight and regulate blood sugar, are now a seemingly permanent part of the weight loss landscape
A one-unit error equals only 25mcg, which is well within acceptable tolerance for most protocols
Because the review of 48 studies, although comprehensive, looked at a wide and diverse group of people -- from those with conditions such as diabetes and kidney disease, and those with different starting and end points and who took different medications -- the conclusions drawn also highlight its limitations
84% in the 10 mg treatment group, 86% in the 20 mg treatment group, and 90% in the 40 mg treatment group
6%), gastritis (2%)
Weight loss injections may lead to modest improvements in cholesterol levels, particularly reductions in total cholesterol, LDL cholesterol, and triglycerides, primarily through weight loss itself